Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
94.10
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook
November 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
November 06, 2023
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
November 06, 2023
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Is BioNTech Stock a Buy Now?
October 25, 2023
Or is it too late to get in on the company after its coronavirus-related success?
Via
The Motley Fool
8 Analysts Have This to Say About BioNTech
October 17, 2023
Via
Benzinga
Price Over Earnings Overview: BioNTech
October 13, 2023
Via
Benzinga
A Look Into BioNTech Inc's Price Over Earnings
October 12, 2023
Via
Benzinga
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
November 02, 2023
The company issued below-consensus sales views for 2023 and 2024.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy for Under $100 Right Now
October 28, 2023
A couple of these stocks might not be available for under $100 for too much longer.
Via
The Motley Fool
7 Undervalued Stocks That Analysts Love Right Now
October 26, 2023
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal.
Via
InvestorPlace
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
The venerable pharmaceutical companies' shares have slumped this year.
Via
The Motley Fool
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
October 19, 2023
The transition to the commercial market is planned for 2024 and could bolster sales.
Via
Investor's Business Daily
Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry
October 05, 2023
Via
Benzinga
7 Stocks That Are Heading for a Train Wreck
October 19, 2023
There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now.
Via
InvestorPlace
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
October 16, 2023
Via
Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
Benzinga Bitcoin Spiked On False ETF Approval Rumor
Via
Benzinga
Topics
ETFs
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
October 16, 2023
Pfizer cut about $9 billion from its sales expectations for Covid products this year.
Via
Investor's Business Daily
Exposures
COVID-19
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
October 16, 2023
Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves.
Via
Benzinga
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.
Via
Benzinga
Exposures
COVID-19
Pfizer Cuts Annual Revenue Guidance By $9B Amid COVID-19 Vaccine Sales Slump, BioNTech Warns €900M Write-Offs
October 16, 2023
Friday, Pfizer Inc (NYSE: PFE) slashed its full-year earnings and revenue guidance, citing decreasing demand for its
Via
Benzinga
Exposures
COVID-19
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 16, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Cut Your Losses: Sell These 7 Weak Stocks Now
October 16, 2023
You can't let weakness in a company or the market damage your portfolio. Avoid disappointing returns by moving on these stocks to sell.
Via
InvestorPlace
Is Novavax Stock a Buy Now?
October 16, 2023
Is this company just a pandemic stock?
Via
The Motley Fool
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...
Via
Talk Markets
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
Vaccine revenue may have slipped but could still represent billions of dollars for these companies.
Via
The Motley Fool
Exposures
COVID-19
7 Innovator Stocks Primed for Exceptional Growth
October 10, 2023
These featured, inventive companies are not only transforming old sectors but also building bridges toward new ones.
Via
InvestorPlace
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.
Via
Benzinga
Exposures
COVID-19
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
October 05, 2023
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.